Salary will be commensurate with experience and includes full benefits. The position is for a year, which can be renewed based on performance and availability of funds.
The project is aimed at developing nanoparticles as a platform for creating a universal influenza vaccine and will involve nanoparticle development and characterization, and investigation of systemic and mucosal immune responses in vivo.
More information about Gill Laboratory can be obtained at www.gill-lab.che.ttu.edu
To apply
Interested candidates should email Dr. Gill their CV, a brief statement of research interest and three names of references at harvinder.gill@ttu.edu. Write 'influenza vaccine postdoc position' in the subject of the email when applying.
For More Information